Cancer Research Cancer Epigenetics Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mao, Y.
Right arrow Articles by Muller, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mao, Y.
Right arrow Articles by Muller, M. T.
[Cancer Research 60, 4538-4543, August 15, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

p53 Dependence of Topoisomerase I Recruitment in Vivo1

Yinghui Mao, Shoshiro Okada, Long-Sheng Chang and Mark T. Muller2

Department of Molecular Genetics, The Ohio State University [Y. M., S. O., M. T. M.], and Department of Pediatrics, Children’s Hospital [L-S. C.], Columbus, Ohio 43210

DNA damage is attended by rapid recruitment of endogenous type I topoisomerase (topo I) into covalent cleavage complexes with genomic DNA in vivo. In contrast, endogenous topoisomerase II {alpha} and ß are not stimulated by DNA damage. We show that topo I and p53 are able to associate at arrested topo I-genomic DNA covalent complexes in vivo, suggesting that p53 directly stimulates topo I activity and damage to the genome of the afflicted cell. Moreover, cells that express wild-type p53 are most proficient at recruiting topo I after DNA damage; however, the p53 dependence is conditional because topo I recruitment after DNA damage can be restored if p53 mutant cells (containing a single mutant allele) are artificially held in G1. In contrast, p53 null mutants do not recruit topo I after DNA damage under any conditions (although camptothecin-dependent topo I/DNA complexes readily form in the nulls). These results show that topo I activation after DNA damage depends on the p53 status of the cell. It also depends upon the cell cycle in a way that is very different from that observed with DNA replication-dependent, camptothecin-mediated DNA breaks. The data suggest a model where p53 activates topo I, which inflicts additional genomic damage after the initial UV damage events. Topoisomerases therefore contribute to the p53 commitment to apoptosis, and topo I might assist in elimination of DNA-damaged cells as part of the cellular proofreading function inherent in the p53 pathway.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Goswami, S. Qiu, T. S. Dexheimer, P. Ranganathan, R. Burikhanov, Y. Pommier, and V. M. Rangnekar
Par-4 Binds to Topoisomerase 1 and Attenuates Its DNA Relaxation Activity
Cancer Res., August 1, 2008; 68(15): 6190 - 6198.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann
NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity
Cancer Res., January 15, 2007; 67(2): 455 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Baumann, G. S. Boehden, A. Burkle, and L. Wiesmuller
Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53
Nucleic Acids Res., February 9, 2006; 34(3): 1036 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Napoli, A. Valenti, V. Salerno, M. Nadal, F. Garnier, M. Rossi, and M. Ciaramella
Reverse Gyrase Recruitment to DNA after UV Light Irradiation in Sulfolobus solfataricus
J. Biol. Chem., August 6, 2004; 279(32): 33192 - 33198.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. O. Christensen, R. M. Krokowski, H. U. Barthelmes, R. Hock, F. Boege, and C. Mielke
Distinct Effects of Topoisomerase I and RNA Polymerase I Inhibitors Suggest a Dual Mechanism of Nucleolar/Nucleoplasmic Partitioning of Topoisomerase I
J. Biol. Chem., May 21, 2004; 279(21): 21873 - 21882.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. R. Kang, M. T. Muller, and I. K. Chung
Telomeric DNA Damage by Topoisomerase I: A POSSIBLE MECHANISM FOR CELL KILLING BY CAMPTOTHECIN
J. Biol. Chem., March 26, 2004; 279(13): 12535 - 12541.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Malanga and F. R. Althaus
Poly(ADP-ribose) Reactivates Stalled DNA Topoisomerase I and Induces DNA Strand Break Resealing
J. Biol. Chem., February 13, 2004; 279(7): 5244 - 5248.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. O. Christensen, H. U. Barthelmes, F. Boege, and C. Mielke
Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro
Nucleic Acids Res., December 15, 2003; 31(24): 7255 - 7263.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Soe and F. Grosse
p53 stimulates human topoisomerase I activity by modulating its DNA binding
Nucleic Acids Res., November 15, 2003; 31(22): 6585 - 6592.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K. Liu, Y. F. Wang, C. Cantemir, and M. T. Muller
Endogenous Assays of DNA Methyltransferases: Evidence for Differential Activities of DNMT1, DNMT2, and DNMT3 in Mammalian Cells In Vivo
Mol. Cell. Biol., April 15, 2003; 23(8): 2709 - 2719.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
H. Stephan, F. Grosse, and K. Soe
Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro
Nucleic Acids Res., December 1, 2002; 30(23): 5087 - 5093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. O. Christensen, H. U. Barthelmes, F. Boege, and C. Mielke
The N-terminal Domain Anchors Human Topoisomerase I at Fibrillar Centers of Nucleoli and Nucleolar Organizer Regions of Mitotic Chromosomes
J. Biol. Chem., September 20, 2002; 277(39): 35932 - 35938.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Pourquier, C. Gioffre, G. Kohlhagen, Y. Urasaki, F. Goldwasser, L. W. Hertel, S. Yu, R. T. Pon, W. H. Gmeiner, and Y. Pommier
Gemcitabine (2',2'-Difluoro-2'-Deoxycytidine), an Antimetabolite That Poisons Topoisomerase I
Clin. Cancer Res., August 1, 2002; 8(8): 2499 - 2504.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. El-Hizawi, J. P. Lagowski, M. Kulesz-Martin, and A. Albor
Induction of Gene Amplification as a Gain-of-Function Phenotype of Mutant p53 Proteins
Cancer Res., June 1, 2002; 62(11): 3264 - 3270.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Soe, G. Dianov, H.-P. Nasheuer, V. A. Bohr, F. Grosse, and T. Stevnsner
A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro
Nucleic Acids Res., August 1, 2001; 29(15): 3195 - 3203.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Mao, I. R. Mehl, and M. T. Muller
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status
PNAS, February 5, 2002; 99(3): 1235 - 1240.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.